Multiple sclerosis: monitoring long-term treatments in multiple sclerosis.
Patients with relapsing-remitting multiple sclerosis have been shown to benefit from disease-modifying treatments over prolonged periods. More focus should now be placed on monitoring the long-term evolution of this disease (making use of tools such as MRI), alongside the patients' response and adherence to such treatments.
Filippi
Massimo
M
Rocca
Maria A
MA
D001921:Brain / Q000187:drug effects / Q000473:pathology; D002986:Clinical Trials as Topic; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000473:pathology; D020127:Recovery of Function; D012720:Severity of Illness Index
D007166:Immunosuppressive Agents